.
06 enero 2020
PharmaMar (OTCMKTS:PHMMF) Upgraded by Zacks Investment Research to Buy . They Currently Have $5.00 Target Price on the Stock. – Slater Sentinel .
Entrada más reciente
Entrada antigua
Inicio